Exploring Trastuzumab Resistance Biomarkers for HER2-positive Breast Cancer Based on Targeted Metabolomics of TCA-Related Metabolites

WEI Bangbang, CAO Yiwei, DONG Chuntao, LI Debang, XU Feifei, SI Xinxin, CHEN Yun

Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (4) : 302-310.

PDF(6756 KB)
PDF(6756 KB)
Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (4) : 302-310. DOI: 10.11669/cpj.2024.04.003

Exploring Trastuzumab Resistance Biomarkers for HER2-positive Breast Cancer Based on Targeted Metabolomics of TCA-Related Metabolites

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 59(4): 302-310 https://doi.org/10.11669/cpj.2024.04.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(6756 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉